HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heinz Reichmann Selected Research

Monoamine Oxidase (MAO)

1/2018Functional monoamine oxidase B gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson's disease.
9/2011Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease.
9/2008Initiation of Parkinson's disease treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heinz Reichmann Research Topics

Disease

82Parkinson Disease (Parkinson's Disease)
11/2023 - 10/2002
20Stroke (Strokes)
03/2024 - 10/2010
15Dyskinesias (Dyskinesia)
11/2023 - 05/2006
11Ischemic Stroke
01/2021 - 12/2009
5Dementia (Dementias)
01/2024 - 10/2006
5Neurodegenerative Diseases (Neurodegenerative Disease)
06/2023 - 03/2011
5Lymphoma (Lymphomas)
12/2020 - 12/2003
5Disease Progression
10/2020 - 08/2013
4Hallucinations (Hallucination)
01/2024 - 01/2016
4Pain (Aches)
10/2021 - 06/2011
4Tremor (Tremors)
01/2016 - 01/2003
4Anhedonia
06/2015 - 01/2003
3Myasthenia Gravis
11/2023 - 12/2021
3Synucleinopathies
10/2022 - 01/2017
3Sleep Apnea Syndromes (Sleep Apnea)
01/2021 - 08/2013
3Alzheimer Disease (Alzheimer's Disease)
01/2020 - 08/2012
3Hematoma
10/2019 - 02/2015
3Cerebral Hemorrhage
10/2019 - 02/2015
3Hepatolenticular Degeneration (Wilson's Disease)
01/2019 - 09/2006
3Parkinsonian Disorders (Parkinsonism)
04/2013 - 09/2006
3Mitochondrial Diseases (Mitochondrial Disease)
07/2011 - 03/2007
2Movement Disorders (Movement Disorder)
10/2022 - 10/2017
2Dystonia (Limb Dystonia)
10/2021 - 10/2019
2Alcoholism (Alcohol Abuse)
11/2020 - 12/2019
2Leukocytosis (Pleocytosis)
10/2020 - 01/2018
2Inflammation (Inflammations)
01/2020 - 01/2010
2Peripheral Nervous System Diseases (PNS Diseases)
12/2019 - 03/2011
2Deglutition Disorders (Dysphagia)
08/2017 - 10/2012
2Anosmia
06/2017 - 08/2016
2Orthostatic Hypotension (Postural Hypotension)
01/2017 - 02/2010
2Friedreich Ataxia (Friedreich's Ataxia)
04/2016 - 03/2011
2Sleepiness
01/2016 - 08/2006
2Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
01/2016 - 06/2015
2Cognitive Dysfunction
03/2011 - 09/2008
2Hypercholesterolemia
11/2010 - 12/2009
2Heart Valve Diseases (Valvular Heart Disease)
01/2007 - 08/2006
1Thrombosis (Thrombus)
03/2024
1Pulmonary Atelectasis
11/2023
1Pneumonia (Pneumonitis)
11/2023
1Sepsis (Septicemia)
11/2023

Drug/Important Bio-Agent (IBA)

17Levodopa (L Dopa)FDA LinkGeneric
11/2023 - 10/2002
13Dopamine Agonists (Dopamine Agonist)IBA
01/2016 - 10/2002
11Dopamine (Intropin)FDA LinkGeneric
01/2022 - 01/2003
10Biomarkers (Surrogate Marker)IBA
02/2021 - 04/2013
6opicaponeIBA
10/2022 - 07/2017
6alpha-SynucleinIBA
07/2020 - 09/2008
6Pramipexole (Mirapex)FDA LinkGeneric
06/2015 - 01/2003
5ropinirole (Requip)FDA LinkGeneric
06/2015 - 01/2007
4EnzymesIBA
01/2022 - 11/2003
4AnticoagulantsIBA
01/2019 - 02/2015
4CabergolineFDA LinkGeneric
06/2015 - 01/2007
3entacapone (Comtan)FDA Link
11/2023 - 02/2012
3RotenoneIBA
01/2021 - 01/2010
3salicylhydroxamic acid (SHAM)IBA
01/2021 - 06/2011
3oxidized low density lipoproteinIBA
01/2020 - 12/2009
3N(4)-oleylcytosine arabinosideIBA
01/2019 - 02/2016
3Monoamine Oxidase (MAO)IBA
01/2018 - 09/2008
3Carbolines (Beta-Carbolines)IBA
06/2011 - 08/2006
2Carbidopa (Lodosyn)FDA LinkGeneric
11/2023 - 02/2012
2Caffeine (No Doz)FDA LinkGeneric
06/2023 - 01/2022
2rotigotineFDA Link
01/2021 - 07/2010
2Methotrexate (Mexate)FDA LinkGeneric
12/2020 - 02/2010
2Cytarabine (Cytosar-U)FDA LinkGeneric
12/2020 - 02/2010
2Proteins (Proteins, Gene)FDA Link
10/2020 - 07/2011
2LipidsIBA
01/2020 - 12/2019
2SynucleinsIBA
01/2019 - 01/2017
2CopperIBA
01/2019 - 09/2006
2Vitamin KFDA Link
01/2019 - 02/2016
2ElementsIBA
01/2017 - 07/2011
2Tissue Plasminogen Activator (Alteplase)FDA Link
01/2017 - 02/2014
2IronIBA
04/2016 - 03/2011
2Dopamine Receptors (Dopamine Receptor)IBA
01/2016 - 10/2006
2Fluoxetine (Prozac)FDA LinkGeneric
10/2015 - 08/2015
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
10/2015 - 08/2015
2amsonic acid (DAS)IBA
06/2015 - 01/2007
2Retinaldehyde (Retinal)IBA
05/2013 - 12/2009
2fluorodopa F 18IBA
05/2013 - 08/2011
2NeurotoxinsIBA
06/2011 - 06/2010
2Cholinesterase Inhibitors (Anticholinesterases)IBA
09/2008 - 10/2006
2Dopamine Agents (Dopaminergic Agents)IBA
12/2007 - 08/2006
2Pergolide (Permax)FDA Link
01/2007 - 08/2006
2Antidepressive Agents (Antidepressants)IBA
10/2006 - 01/2003
2budipineIBA
10/2006 - 05/2006
1TheobromineIBA
06/2023
1Theophylline (Theon)FDA LinkGeneric
06/2023

Therapy/Procedure

34Therapeutics
11/2023 - 01/2003
8Drug Therapy (Chemotherapy)
12/2020 - 12/2003
7Deep Brain Stimulation
04/2023 - 08/2006
5Activities of Daily Living (ADL)
01/2021 - 01/2003
4Blood Component Removal (Apheresis)
01/2020 - 12/2009
3Artificial Respiration (Mechanical Ventilation)
11/2023 - 08/2017
3Aftercare (After-Treatment)
10/2021 - 06/2011
3Radiotherapy
02/2010 - 12/2003
2Home Nursing (Nursing, Home)
01/2024 - 04/2023
2Wearable Electronic Devices
01/2023 - 01/2023
2Tracheostomy
01/2022 - 08/2017
2Secondary Prevention
07/2021 - 01/2016
2Combination Drug Therapy (Combination Chemotherapy)
02/2010 - 02/2009
1Thrombectomy
03/2024
1Cardiopulmonary Resuscitation (CPR)
11/2023